US loss of exclusivity · Immunology
Cosentyx
Novartis
2029
US biosimilars from
2025
Today: 2026
2037
2025 worldwide sales
$6.7B
Date basis
Patent-expiry estimate
US biosimilars
In clinical trials
Medicare price
Pending, from 2028
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Cosentyx timeline →